secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001628280-24-039764
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo posts updated investor presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Filed 8-K on Sept 9, 2024 to announce availability of an updated investor presentation.
- Presentation posted on company website; no specific financial or operational updates provided in filing or exhibit.
- Ticker AVTX; presentation dated September 2024 but content beyond title slide not included in filing text.
- Investor presentation will be used in meetings with investors; no guidance or material events announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828024039764/0001628280-24-039764-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828024039764/avtx-20240909.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-039764

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer